Hasil Pencarian - Hagop Kantarjian

Perbaiki Hasil
  1. 1
    Core binding factor acute myelogenous leukemia-2021 treatment algorithm

    Core binding factor acute myelogenous leukemia-2021 treatment algorithm oleh Gautam Borthakur, Hagop Kantarjian

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies

    Immunotherapy in adult acute lymphoblastic leukemia: the role of monoclonal antibodies oleh Elias Jabbour, Hagop Kantarjian

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Acute promyelocytic leukemia current treatment algorithms

    Acute promyelocytic leukemia current treatment algorithms oleh Musa Yilmaz, Hagop Kantarjian, Farhad Ravandi

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Early mortality after chemotherapy as a quality indicator—the leukemia perspective

    Early mortality after chemotherapy as a quality indicator—the leukemia perspective oleh Hagop Kantarjian, Mary Alma Welch, Koji Sasaki

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Development and targeted use of nilotinib in chronic myeloid leukemia

    Development and targeted use of nilotinib in chronic myeloid leukemia oleh Carmen Fava, Hagop Kantarjian, Jorge Cortes, Elias Jabbour

    Diterbitkan 2008-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia oleh Nicholas J. Short, Hagop Kantarjian, Farhad Ravandi, Naval Daver

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia

    The history of oral decitabine/cedazuridine and its potential role in acute myeloid leukemia oleh Robert Briski, Guillermo Garcia-Manero, Hagop Kantarjian, Farhad Ravandi

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia

    The clinical impact of ponatinib on the risk of bleeding in patients with chronic myeloid leukemia oleh Aziz Nazha, Carlos G. Romo, Hagop Kantarjian, Jorge Cortes

    Diterbitkan 2013-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions

    Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions oleh Nicholas J. Short, Elias Jabbour, Nitin Jain, Hagop Kantarjian

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor

    Phase II trial of ponatinib in patients with chronic myeloid leukemia resistant to one previous tyrosine kinase inhibitor oleh David Sanford, Hagop Kantarjian, Jeffrey Skinner, Elias Jabbour, Jorge Cortes

    Diterbitkan 2015-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-term follow-up of the STI571 0102 and 0109 trials

    Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-t... oleh Richard T. Silver, Jorge Cortes, Roger Waltzman, Manisha Mone, Hagop Kantarjian

    Diterbitkan 2009-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    <i>TP53</i> in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation

    <i>TP53</i> in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation oleh Binsah George, Hagop Kantarjian, Natalia Baran, Joseph Douglas Krocker, Adan Rios

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

    Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions oleh Bachar Samra, Elias Jabbour, Farhad Ravandi, Hagop Kantarjian, Nicholas J. Short

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Clinical activity of ponatinib in patients with chronic myeloid leukemia in chronic phase with e1a2 transcripts

    Clinical activity of ponatinib in patients with chronic myeloid leukemia in chronic phase with e1a2 transcripts oleh Preetesh Jain, Carlos Guillermo Romo, Hanna J. Khoury, Hagop Kantarjian, Jorge Cortes

    Diterbitkan 2013-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Relapse and death during first remission in acute myeloid leukemia

    Relapse and death during first remission in acute myeloid leukemia oleh Masamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, Farhad Ravandi, Hagop Kantarjian, Elihu Estey

    Diterbitkan 2008-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia

    Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia oleh Veronica A. Guerra, Elias J. Jabbour, Farhad Ravandi, Hagop Kantarjian, Nicholas J. Short

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia

    Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia oleh Masamitsu Yanada, Gautam Borthakur, Farhad Ravandi, Carlos Bueso-Ramos, Hagop Kantarjian, Elihu Estey

    Diterbitkan 2008-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.

    Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling. oleh Tai-Sung Lee, Hagop Kantarjian, Wanlong Ma, Chen-Hsiung Yeh, Francis Giles, Maher Albitar

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

    The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades oleh Elias Jabbour, Nicholas J. Short, Nitin Jain, Fadi G. Haddad, Mary Alma Welch, Farhad Ravandi, Hagop Kantarjian

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia

    Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia oleh Aram Bidikian, Hagop Kantarjian, Elias Jabbour, Nicholas J. Short, Keyur Patel, Farhad Ravandi, Koji Sasaki, Ghayas C. Issa

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: